PD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature Review. Zhou M, Joshi N, Raj KP, Wakelee H, et al. Clin Lung Cancer 2021;22:e329-e335.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou M, Joshi N, Raj KP, Wakelee H, et al. PD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature Review. Clin Lung Cancer 2021;22:e329-e335.
PMID: 32624413